Creekwood Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CREEKWOOD PHARMS, and what generic and branded alternatives to CREEKWOOD PHARMS drugs are available?
CREEKWOOD PHARMS has five approved drugs.
Drugs and US Patents for Creekwood Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Creekwood Pharms | HYDROXYCHLOROQUINE SULFATE | hydroxychloroquine sulfate | TABLET;ORAL | 040150-001 | Jan 27, 1996 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Creekwood Pharms | RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET;ORAL | 202047-002 | Dec 31, 2012 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Creekwood Pharms | FENOFIBRATE | fenofibrate | TABLET;ORAL | 217732-001 | Sep 7, 2023 | BX | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Creekwood Pharms | PREGABALIN | pregabalin | CAPSULE;ORAL | 213423-008 | Mar 23, 2020 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Creekwood Pharms | PREGABALIN | pregabalin | CAPSULE;ORAL | 213423-001 | Mar 23, 2020 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Creekwood Pharms | SILODOSIN | silodosin | CAPSULE;ORAL | 213230-002 | Jan 3, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Creekwood Pharms | RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET;ORAL | 202047-001 | Dec 31, 2012 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.